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Abstract
Variant late-infantile neuronal ceroid lipofuscinosis, a fatal lysosomal storage disorder accompanied by regional atrophy and
pronounced neuron loss in the brain, is caused by mutations in the CLN6 gene. CLN6 is a non-glycosylated endoplasmic
reticulum (ER)-resident membrane protein of unknown function. To investigate mechanisms contributing to
neurodegeneration in CLN6 disease we examined the nclf mouse, a naturally occurring model of the human CLN6
disease. Prominent autofluorescent and electron-dense lysosomal storage material was found in cerebellar Purkinje cells,
thalamus, hippocampus, olfactory bulb and in cortical layer II to V. Another prominent early feature of nclf pathogenesis was
the localized astrocytosis that was evident in many brain regions and the more widespread microgliosis. Expression analysis
of mutant Cln6 found in nclf mice demonstrated synthesis of a truncated protein with a reduced half-life. Whereas the rapid
degradation of the mutant Cln6 protein can be inhibited by proteasomal inhibitors, there was no evidence for ER stress or
activation of the unfolded protein response in various brain areas during postnatal development. Age-dependent increases
in LC3-II, ubiquitinated proteins, and neuronal p62-positive aggregates were observed, indicating a disruption of the
autophagy-lysosome degradation pathway of proteins in brains of nclf mice, most likely due to defective fusion between
autophagosomes and lysosomes. These data suggest that proteasomal degradation of mutant Cln6 is sufficient to prevent
the accumulation of misfolded Cln6 protein, whereas lysosomal dysfunction impairs constitutive autophagy promoting
neurodegeneration.
Citation: Thelen M, Damme M, Schweizer M, Hagel C, Wong AMS, et al. (2012) Disruption of the Autophagy-Lysosome Pathway Is Involved in Neuropathology of
the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis. PLoS ONE 7(4): e35493. doi:10.1371/journal.pone.0035493
Editor: Wanjin Hong, Institute of Molecular and Cell Biology, Singapore
Received January 12, 2012; Accepted March 16, 2012; Published April 20, 2012
Copyright:  2012 Thelen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was financed by the Swiss National Science Foundation (http://www.snf.ch) PA00A3-117483; the Deutsche Forschungsgemeinschaft (http://
www.dfg.de) FG885; the Wellcome Trust (http://www.wellcome.ac.uk/) GR079491MA; the Batten Disease Support and Research Association (http://www.bdsra.
org/); the Batten Disease Family Association (http://www.bdfa-uk.org.uk/); the Natalie Fund (http://nataliefund.org/); and parent organisation Na ¨chstenliebe e.V.
(cgh 0328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: g.galliciotti@uke.uni-hamburg.de
. These authors contributed equally to this work.
Introduction
Neuronal ceroid lipofuscinoses (NCL) are a group of severe
neurodegenerative lysosomal storage disorders, and are considered
the most common progressive encephalopathies of childhood [1].
The NCLs are caused by mutations in at least nine human CLN
genes, which can be linked to the onset and clinical course of the
disease [1,2]. The different forms share common clinical features,
including progressive loss of vision, mental and motor deteriora-
tion, epileptic seizures, and premature death [3]. These disorders
are characterized by accumulation of autofluorescent ceroid
lipopigments in most tissues, but pathological effects are most
pronounced in the central nervous system, which displays a
progressive and remarkably selective loss of neurons [4,5]. The
CLN6 gene encodes a polytopic non-glycosylated membrane
protein of unknown function. CLN6 is localized in the ER [6,7]
and widely expressed in many tissues [8,9]. In the mouse brain,
high Cln6 mRNA levels are found in diverse neuronal populations,
in layer II-VI of the cerebral cortex, the hippocampal CA1 and
dentate gyrus regions, and in the cerebellar Purkinje cell layer
[10]. CLN6 is conserved across vertebrates showing no sequence
homology with other proteins. Mutations in CLN6 cause variant
late-onset neuronal ceroid lipofuscinosis (vLINCL [8,9]) as well as
an adult form of the disease [11]. Among the 55 disease-causing
mutations identified in the CLN6 gene (http://www.ucl.ac.uk/ncl/
cln6.shtml), a 1-bp insertion in exon 4 (c.316insC) causes a frame
shift and a premature stop codon [12] leading to the production of
a truncated protein (p.R106PfsX26). In the mouse ortholog, an
identical mutation (c.307insC) has been identified in nclf mice
[7,8], a naturally occurring model for CLN6 disease recapitulating
the phenotype of the disease [13]. Homozygous nclf mice develop
progressive retinal atrophy early in life, show cerebral atrophy,
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at one year of age.
Little is known about the mechanisms leading to neurodegen-
eration in any form of NCL. Whereas the accumulation of storage
material increases linearly with age, in some brain regions a more
rapid progression of the disease has been observed [14]. Indeed,
the rate and distribution of accumulating lipofuscin-like lipopig-
ments correlate only partially with the severity of the neuron loss,
and not all cells exhibiting increased storage material go on to die
[15]. It is also apparent that this stored material is complex in
nature with accumulation of the c-subunit of mitochondrial ATP
synthase or saposins, and secondary accumulating lipids such as
glycosphingolipids, cholesterol, dolichol, ubiquinone or bis(mo-
noacylglycero)phosphate [16,17]. Rather than storage material
accumulation, localized activation of glia is more closely related to
the distribution of subsequent neuron loss [14,18,19]. Thus, sites
showing early reactive changes display the most pronounced
neuron loss, with selective loss of different subtypes of GABAergic
interneurons in these brain regions [14,20].
ER stress activation due to the accumulation of misfolded
proteins leads to unfolded protein response (UPR) and has already
been reported in several neurodegenerative disorders, including
some forms of NCL [21,22]. A consequence of UPR is the
activation of the ubiquitin-proteasome system, which is responsible
for degradation of misfolded proteins or small aggregates [23,24].
In addition, the constitutive autophagy-lysosome pathway serves
the degradation of long-lived proteins, damaged organelles,
clearance of toxic protein aggregates and intracellular pathogens
[25]. Recent studies showed that loss of autophagy results in
cytoplasmic accumulation of ubiquitin-positive aggregates and
neurodegeneration [26,27]. For CLN3 and CLN10, a disturbance
of autophagy has already been shown [28,29]. Both proteasomal
and autophagic systems are indispensable for maintaining cellular
homeostasis by working in a coordinated way in removing some
abnormal proteins [30].
In this study, we have investigated several mechanisms such as
proteasomal degradation, ER stress, autophagy and reactive
gliosis, which might contribute to neurodegeneration in CLN6
disease using nclf mice as a model system.
Results
Gross morphology of the central nervous system and
distribution of lipopigments
Examination of Nissl stained sagittal sections from 54 weeks old
wild-type and nclf mice (Figure 1A) revealed reduced size of the
cerebellum in nclf mice in comparison to controls. The median
weight of nclf mice brain at one year of age was reduced by 25%
compared to wild-type brains, indicating severe atrophy of the
brain.
The distribution of the autofluorescent lysosomal storage
material was evaluated on unstained sections of 54 weeks old nclf
mice and age matched control animals by confocal fluorescence
microscopy (Figure 1B). Lipopigments were found to accumulate
throughout the entire brain in both neurons and microglia. In the
cerebellum, Purkinje cells were the cell type with the greatest
storage burden, bearing brightly autofluorescent storage material
in the entire soma. The thalamus was populated with lipopigment-
laden cells. All hippocampal neurons of Ammon’s horn exhibited a
bright autofluorescence. Neurons from the cerebral cortex
contained graded levels of storage material with increasing
amounts of lipopigments from layer I to layer V. Several other
regions of the brain contained prominent accumulation of storage
material, including the olfactory bulb. Ultrastructural examination
of intralysosomal storage material (Figure 1C) revealed abnormally
increased amounts of dense bodies with a typical lipopigment-like
appearance with membrane bound rectilinear and fingerprint-
profiles. Occasionally, nclf neurons exhibited swollen processes
(Figure 1C) filled with heterogenous membrane bound storage
vacuoles, dense and multilamellar bodies.
Neuroinflammation in nclf mice
Activated astrocytes are found early in disease progression in
CLN6-deficient New Zealand South Hampshire sheep [14], with
localized GFAP immunoreactivity accurately predicting the
distribution of subsequent neuron loss. Analysis of GFAP
immunoreactivity in nclf mice revealed a similar distribution as
in affected sheep with localized astrocytosis in individual nuclei of
the thalamus and deeper cortical layers in presymptomatic mice at
21 weeks of age. Many intensely stained GFAP positive astrocytes
were present in a variety of brain regions. As in mouse models of
other forms of NCL [31], this localized astrocytosis was most
prominent in individual thalamic sensory relay nuclei (Figure 2)
including the ventral posterior (somatosensory relay) and dorsal
lateral geniculate (visual relay) and the corresponding regions of
somatosensory and visual cortex, together with the caudate
putamen. In the cerebellum, astrocyte activation appeared
relatively late (52 weeks) in disease progression and was restricted
to the granular layer and white matter (Figure S1). No obvious loss
of Purkinje cells was observed (data not shown), although these
cells were particularly strong affected by accumulation of
lipopigments (Figure 1B).
In addition to astrocytosis, microglial activation is common in
other NCLs and a remarkable feature of CLN6-deficient sheep
[14]. Highly activated microglia appeared early in the course of
the disease of nclf mice, transforming to a phagocytotic shape in
54 weeks old animals (Figure 3). The distribution of activated
microglia closely resembled that of lipopigment storage. Although
local distribution of activated astrocytes and microglia was similar,
with clusters of microglia in most nuclei of the thalamus, the
olfactory bulb, caudate putamen, the granular layer and white
matter of the cerebellum, microglial activation was more
widespread and generalized in the entire brain. However, no
prominent activation of perivascular macrophages was observed.
Proteasomal degradation of mutant Cln6
In order to investigate the potential role of the mutant Cln6
protein in the pathogenesis of the nclf mouse, we introduced the
c.307insC mutation into the murine Cln6 cDNA by site-directed
mutagenesis. This insertion leads to a frame shift and a nonsense
sequence of 62 amino acids, terminating in a premature stop
codon (p.R103PfsX62). The synthesis and stability of the murine
wild-type and mutant p.R103PfsX62 Cln6 were investigated in
BHK cells overexpressing both proteins N-terminally fused to
GFP. Transfected cells were metabolically labelled with [
35S]-
methionine for two hours and chased for different time periods
followed by immunoprecipitation and fluorography. Wild-type
GFP-Cln6 is synthesized as a 55 kDa protein. Quantification of
radioactivity incorporated into immunoprecipitated GFP-Cln6
revealed a reduction of more than 50% during a 24 hours chase
period (Figure 4, lanes 1 and 5). In contrast, small amounts of
42 kDa mutant p.R103PfsX62 GFP-Cln6 protein were synthe-
sized and after 24 hours chase no [
35S]-labelled polypeptides were
recovered by immunoprecipitation (Figure 4, lanes 3 and 7). In the
presence of the irreversible proteasomal inhibitor epoxomicin
(2 mM) the amounts of immunoprecipitated wild-type GFP-Cln6
were not altered (Figure 4, lanes 2 and 6), whereas epoxomicin
prevented the degradation of mutant p.R103PfsX62 GFP-Cln6
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did not prevent the degradation of mutant Cln6 during the
24 hours chase period (Figure 4, lane 8). Taken together, these
data demonstrate that mutant p.R103PfsX62 Cln6 is synthesized
as a truncated protein that is rapidly degraded by the proteasome
system.
ER stress is not activated in brains of nclf mice
To examine whether the rapid proteasomal degradation of
mutant p.R103PfsX62 Cln6 leads to ER stress and the activation
of UPR, the expression of several ER stress marker proteins was
examined in cerebellar extracts of 4, 12, 21 and 43 weeks old nclf
mice. Densitometric evaluation of western blots normalized to the
tubulin expression revealed no significant differences in phosphor-
ylation of eukaryotic initiation factor 2 alpha (phospho eIF2alpha)
and expression of immunoglobulin heavy chain binding protein
BiP and cytosolic heat shock protein 70 (Hsp70) between wild-type
and nclf mice of any age (Figure 5). Similar results were obtained
when extracts of cerebral cortex were analyzed (data not shown).
Immunohistochemical staining failed to show regional or temporal
differences in the expression of BiP and Hsp70 between wild-type
and nclf mice (data not shown). These data suggest that the
proteasomal degradation of mutant p.R103PfsX62 Cln6 is
sufficient to prevent the accumulation of misfolded Cln6 protein
and the subsequent activation of ER stress.
Increased autophagy in the nclf mouse brain
Since autophagy has been shown to play a role in the
pathogenesis of other forms of NCL, including CLN3 and
CLN10 [5,28,29], we investigated whether this lysosomal
Figure 1. Storage material in nclf mouse brain. A) Sagittal mouse brain sections were stained with Nissl staining, showing cerebellar atrophy in
the nclf brain. B) Autofluorescent storage material was evident in cerebellum, thalamus, hippocampus and cortex of 54 weeks old nclf mice but not in
age-matched wild-type controls. The selected areas are shown in panel A (a, b, c, d). Scale bars: 300 mm. C) Ultrastructural analysis showed storage
material in cerebellum and hippocampus of the brain of 52 weeks old nclf mice. Scale bar: 2 mm.
doi:10.1371/journal.pone.0035493.g001
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lipidated autophagosomal marker microtubule-associated protein
1 light chain 3-II (LC3-II) and p62 are known to accumulate upon
inhibition of autophagy [25]. Comparative LC3 western blots of
whole brain extracts of wild-type and nclf mice at different ages
revealed 2.6- and 3.6-fold higher levels of LC3-II in 40 and
52 weeks old nclf mice, respectively (Figure 6 A, B). In
presymptomatic 20 weeks old mice, no significant differences in
the LC3-II levels could be detected between wild-type and nclf
mice (Figure 6 B). These results could be verified by LC3
immunohistochemistry (Figure S2 B), showing increased amounts
of granular LC3 positive material in the brains of older nclf mice. A
small, but not statistically significant, increase in the number of
autophagic vacuoles could also be observed in hippocampal
neurons of nclf mice cultured for 14 days (Figure 6 C, D).
p62 has been reported to act as a receptor for autophagic cargo
by interaction with ubiquitinated proteins and LC3 [32]. In brains
of nclf mice, p62-positive material could be detected already at an
age of 20 weeks (Figure S2 A) in neurons of the olfactory bulb,
cerebral cortex and the hippocampus. In 54 weeks old nclf mice
(Figure 7 A), numerous p62-positive aggregates where found in the
entire brain, but less frequently in the cerebellum and medulla.
The size of p62-positive aggregates varied considerably between 1
and 10 mm. The distribution of p62 aggregates only partially
resembled that of lipopigment material. In the thalamus, which
showed a prominent accumulation of lipopigments (Figure 1 B), no
p62-positive aggregates were found. In contrast, in layer I of the
cortex, that exhibited high levels of p62 aggregates, lipopigments
were absent. Double immunofluorescence microscopy showed a
colocalization of p62 with NeuN-positive neuronal cells, but not
with glial cells stained for the microglial and astrocytic markers
CD68 and GFAP, respectively (Figure 7 B). To examine whether
the increase in the number of LC3-II and p62-positive
autophagosomes is due to signalling events initiating autophagy
[25], the expression of Beclin-1 was determined in brain extracts of
nclf mice at different ages. No changes in the expression of Beclin-1
were observed in the brain between wild-type and nclf mice
(Figure S3). Since p62 did not colocalize with the lysosomal
marker protein Lamp1 (Figure 7 B), the data suggest that the
fusion between p62-positive autophagosomes and lysosomes is
inhibited.
Western blot analysis showed that p62 was mainly found in the
Triton X-100 insoluble fraction of nclf brain extracts, whereas only
low amounts of p62 were observed in wild-type brain (Figure 7 C).
In addition, the p62-positive insoluble fraction of nclf brain
contained high levels of ubiquitinated proteins (Figure 7 C). These
data suggest that the lysosomal dysfunction in neurons of nclf mice
leads to accumulation of autophagosomes, most likely due to
defective fusion processes with lysosomes and subsequent forma-
tion of aggregates of p62 and ubiquitinated substrate proteins.
Discussion
The nclf mouse provides a valuable tool for investigating the
molecular mechanisms underlying this variant form of late
infantile NCL. The single cytosine insertion (c.307insC) in the
Cln6 gene of nclf mice was also found in three families of Pakistan
origin (c.316insC). These mutations are responsible for frameshifts
and production of truncated proteins, p.R103PfsX62 and
p.R106PfsX26, respectively [8,9,12]. The present expression
studies showed that the newly synthesized mutant p.R103PfsX62
Cln6 is rapidly degraded similarly to mutant human CLN6 [12].
The comparable half-lives of mutant human CLN6 and murine
Cln6 indicate that the GFP-tag does not affect the stability of the
mutant Cln6 protein. Inhibitor studies suggest that both mouse
and human truncated Cln6/CLN6 proteins are degraded after
retranslocation to the cytoplasm by the ubiquitin-proteasome
pathway. Due to the lack of sufficiently specific antibodies
Figure 2. Localized astrocytosis in nclf mice. Immunohistochemical staining for glial fibrillary associated protein (GFAP) revealed pronounced
upregulation of this marker of astrocytosis in 21 weeks old nclf mice compared to age-matched wild-type controls (wt). Intense localized astrocytosis
was evident in the ventral posterior (VPM/VPL) and dorsal lateral geniculate (LGNd) relay nuclei of the thalamus of nclf mice, with more diffuse
scattered GFAP positive astrocytes present predominantly in deeper (V-VI) and more superficial (I-III) laminae of the cortical mantle. Compared to wt
controls, many GFAP stained astrocytes were also evident in the caudate-putamen of nclf mice. Laminar boundaries are indicated by roman numerals
and white dashed lines indicate the boundaries of thalamic relay nuclei. Scale bar: 100 mm.
doi:10.1371/journal.pone.0035493.g002
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unclear whether the proteasomal degradation is sufficient to
prevent i) the accumulation of the misfolded mutant
p.R103PfsX62 Cln6 in the ER or ii) its aggregation in the cytosol.
However, the accumulation of misfolded mutant Cln6 in ER of
nclf brain cells and the subsequent activation of ER stress and UPR
is rather unlikely, because we observed a rapid degradation of
mutant Cln6 and we did not find changes in the expression of BiP,
an ER luminal chaperone and marker of UPR [33]. Therefore,
our data do not support the assumption that UPR represents a
common pathway activated in neurodegenerative lysosomal
storage diseases [21]. In line with our data, Futerman and
colleagues failed to find evidence of activated UPR in models of
neuropathic Gaucher disease [34]. Therefore, whereas activation
of UPR has been reported in brain tissue and cultured neurons of
mice deficient for the lysosomal palmitoyl protein thioesterase-1, a
mouse model of human infantile NCL (CLN1) [22], our data lead
us to conclude that different pathogenetic mechanisms are
responsible for the relatively similar clinical symptoms and
neurodegeneration in Cln1-deficient and Cln6-defective mouse
models.
The cytosolic aggregation of mutant p.R103PfsX62 Cln6 also
appears to be unlikely, because no alterations in the expression of
Hsp70 were observed in brain extracts of nclf mice. Hsp70 plays an
important role in the retranslocation and clearance of misfolded
Figure 3. Activation of microglia in nclf brain. Immunohistochemical stainings of sagittal mouse brain sections showed a prominent
microgliosis as assessed by the microglial marker CD68 at 54 weeks of age in nclf and wild-type (wt) mice. Scale bars. 500 mm. In the right panel,
higher magnification images of the areas marked by the black rectangles are shown.
doi:10.1371/journal.pone.0035493.g003
Figure 4. Mutant GFP-Cln6 is rapidly degraded by protea-
somes. BHK cells overexpressing murine wild-type or mutant
p.R103PfsX62 GFP-Cln6 (mut) were labelled for 24 hours with [
35S]-
methionine (75 mCi/ml) and either harvested or chased for 3 (lanes 1–4)
and 24 hours (lanes 5–8) in the absence (–) or presence (+) of the
proteasomal inhibitor epoxomicin (2 mM). GFP-Cln6 fusion proteins
were immunoprecipitated, separated by SDS-PAGE (10% acrylamide)
and revealed by fluorography. A representative experiment out of three
is shown. The [
35S]-labelled bands of the presented experiment were
excised from the gel, solubilized and counted. The values are given
above the lanes.
doi:10.1371/journal.pone.0035493.g004
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constitutive clearance of damaged organelles and aggregated
proteins that might be toxic, especially in post-mitotic cells like
neurons, is autophagy [36]. Autophagy can be rapidly induced,
e.g. by nutrient starvation or UPR, or can operate constitutively to
degrade long-lived or aggregate-prone proteins, culminating in the
formation of double membrane autophagosomes [25]. This
process is assisted by the formation of a lipidated autophago-
some-specific protein, LC3-II, whose content correlates with the
number of autophagosomes [37]. The segregated cytosolic
material and organelles, such as mitochondria, are then degraded
by lysosomal hydrolases after fusion with lysosomes. Whereas the
majority of degradation products are exported by membrane
transporters to allow their reuse, indigestible material and
lipopigments may remain in autolysosomes. Autophagy has been
reported to be blocked during the pathogenesis of several
lysosomal storage diseases, including CLN3 and CLN10
[28,29,38]. The presence of autophagic vacuoles in cultured
neuronal cells and in the brain of nclf mice, and the age-dependent
increase in LC3-II immunoreactive material suggests that the
autophagic degradative pathway is upregulated or impaired.
Impairment of autophagosome-lysosome fusion might be due to
accumulation of undegraded substrates and/or lysosomal dys-
function [38,39]. Although the origin(s) of the membranes that
form new autophagosomes are unclear, it has been proposed that
the ER supplies the material for the growing membrane [30].
Thus, disruption of ER function caused by mutant Cln6 could
Figure 5. Analysis of ER stress and unfolded protein response markers in nclf mice. Cerebellar extracts from wild-type and nclf mice of 4,
12, 21, and 43 weeks of age were analyzed for eIF2alpha phosphorylation and for Hsp70 and BiP expression by western blotting. No major differences
were detectable between the genotypes. Tubulin was used as loading control. Representative blots of three mice of different litters are shown.
doi:10.1371/journal.pone.0035493.g005
Figure 6. Accumulation of autophagosomes in nclf brain and hippocampal neurons. A) Accumulation of autophagosomes was assessed
by determining the levels of the autophagic marker protein microtubule-associated protein 1 light chain 3 -II (LC3-II) in wild-type or nclf total mouse
brain extracts at 54 weeks of age by western blotting. B) Densitometric quantification of LC3-II levels normalized to tubulin as a loading control
revealed enhanced autophagosome numbers with increasing age. Data are presented as mean 6SD, n=3 per age. Wild-type values were set to 1. C)
Double-membrane autophagic vacuoles (marked by arrows) were also found in hippocampal neurons from nclf mice cultured for 14 days. D) For
quantification of autophagic vacuoles, pictures were taken from 37 randomly selected wild-type and nclf neurons of two different preparations. The
number of autophagic vacuoles related to the cytoplasmic area was determined. Data are presented as mean 6 S.E.M. Scale bars: 1 mm.
doi:10.1371/journal.pone.0035493.g006
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subsequently block this pathway.
Our electron microscopic analysis revealed that intralysosomal
storage material was already present at postnatal day 10,
increasing with age in nclf mice. p62-positive, detergent-insoluble
material and p62-positive neuronal aggregates have been found in
the brains of presymptomatic nclf mice. The multifunctional LC3-
II and ubiquitin-binding protein p62 [32] mediates the degrada-
tion of ubiquitinated proteins via the autophagosome-lysosome
pathway. Therefore, the reduced autophagic activity in the nclf
brain is accompanied by the accumulation of ubiquitinated
proteins in p62-positive cytoplasmic aggregates known to be toxic
for cells. A coordinated and/or compensatory action of the
ubiquitin-proteasome degradative pathway and autophagy has
already been described for other proteins, including alpha-
synuclein and alpha1-antitrypsin Z [40,41,42].
A consistent feature of NCL pathogenesis is the early and
localized activation of astrocytes [18]. This phenotype was first
described in CLN6-deficient South Hampshire sheep [14], and
our data from nclf mice reveal for the first time that this is
maintained across species boundaries, being present in this mouse
model of CLN6 disease. Although early astrocytosis invariably
precedes neuron loss in multiple forms of NCL [31,43,44], it is
presently unclear whether these events are causally related in
CLN6 deficiency. As in many other forms of NCL, it is clear that
the thalamocortical system is a particular focus of astrocyte
activation in nclf mice, but to date very little is known about the
sequence of neuron loss in these pathways. Since it is becoming
clear that the precise nature and relative timing of astrocytosis,
microglial activation and neuron loss differ markedly between
forms of NCL [45], it will be important to define the onset and
progression of these events more precisely in nclf mice. Although
these findings contribute to the understanding of the complex
Figure 7. Aggregates of p62 and ubiquitinated proteins in brains of nclf mice. A) Immunohistochemical analysis of brain sections (35 mm
thickness) of 54 weeks old mouse showed p62-positive aggregates in nclf but not wild-type brain regions. The insets show higher magnification
images of the areas marked by the white rectangles. Scale bar: 20 mm. B) p62-positive accumulations showed no colocalization with microglial marker
CD68, astrocytic marker GFAP or the lysosomal membrane protein Lamp-1 as determined by immunofluorescence microscopy in sections of the
olfactory bulb in 54 weeks old nclf mice. Scale bar: 20 mm. C) Western blot analysis confirmed increased p62 levels and show furthermore
accumulation of ubiquitinated proteins in Triton X-100 insoluble fractions of nclf brain.
doi:10.1371/journal.pone.0035493.g007
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mice as a model of the human CLN6 disease, the function of the
ER-resident CLN6 protein and how mutant CLN6 leads to
lysosomal dysfunction require further studies.
Materials and Methods
Materials
Dulbecco’s Modified Eagle’s Medium (DMEM), Minimum
Essential Medium (MEM), fetal calf serum (FCS), Lipofectamine
2000, Taq polymerase and pcDNA3.1/myc-His(+)A vectors were
purchased from Invitrogen (Karlsruhe, Germany). pEGFP-C1
vector was from Clontech (Mountain View, USA). [
35S]-
methionine and Rainbow molecular weight marker were obtained
from GE Healthcare Europe (Freiburg, Germany), epoxomicin
from Calbiochem (Darmstadt, Germany), PhosSTOP phosphatase
inhibitor cocktail was purchased from Roche (Mannheim,
Germany), PhusionH High-Fidelity DNA polymerase from Finn-
zymes (Espoo, Finland) and ProtranH nitrocellulose membrane
from Whatman (Dassel, Germany). Protease inhibitor cocktail and
poly-L-lysine were purchased from Sigma (Munich, Germany).
Oligonucleotides used for cloning and sequencing were synthe-
sized by Eurofins MWG Operon (Ebersberg, Germany).
DNA constructs
Murine Cln6 cDNA (NM_001033175) was purchased from
Deutsches Ressourcenzentrum fu ¨r Genomforschung RZPD (Ber-
lin, Germany), amplified by PCR using primers 59-GAATT-
CATGGAGGCGGCGACGCG-39 and 59-CTCGAGCTGTT-
GACTGCTAACGTG-39 and the resulting PCR product cloned
into the EcoR I- and Xho I-sites of expression vector pcDNA3.1/
myc-His(+)A. The c.307insC mutation was introduced into this
murine Cln6 cDNA using the QuickChange
TM Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA, USA) according to the
manufacturer’s instructions using the following primers: 59-
CCGCGGCAGCGTTCGGGGGGGACCGC–39 and 59-
GCGGTCCCCCCCGAACGCTGCCGCGG–39. Murine wild-
type and c.307insC Cln6 cDNA were cloned into pEGFP-C1
vector, downstream of the green fluorescent protein (GFP) cDNA
sequence.
All constructs were sequenced using ABI PRISM BigDye
Terminator Cycle Sequencing Kit on a Model 377 automated
sequencer (Applied Biosystems, Darmstadt, Germany).
Antibodies
Monoclonal anti-eIF2alpha, anti-phospho-eIF2alpha and anti-
ubiquitin (clone P4D1) antibodies were purchased from Cell
Signaling Technology (Danvers, MA, USA), monoclonal anti-
Hsp70 and anti-BiP from BD Biosciences (Heidelberg, Germany),
monoclonal anti-GFP antibody from Roche, monoclonal anti-LC3
antibody (clone 2G6) was from nanotools Antiko ¨rpertechnik
(Teningen, Germany). Monoclonal mouse and polyclonal rabbit
anti-GFAP antibodies were purchased from Sigma-Aldrich (St
Louis, MO, USA) or DakoCytomation (Glostrup, Denmark),
respectively. The monoclonal mouse anti-neuronal nuclei (NeuN)
antibody (clone A60) was obtained from Millipore (Billerica, MA,
USA). Monoclonal rat anti-CD68 antibody (clone FA-11) was
purchased from AbD Serotec (Oxford, UK). Polyclonal rabbit
anti-p62 antibody was purchased from ENZO Life Sciences
(Plymouth Meeting, PA, USA) (immunohistochemistry) or MBL
International (Woburn, MA, USA) (western blotting). The anti-
beta tubulin monoclonal antibody (clone E7) developed by M.
Klymkowsky was obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the NICHD
and maintained by The University of Iowa, Department of
Biological Sciences, Iowa City. Horseradish peroxidase-conjugat-
ed goat anti-mouse and goat anti-rabbit IgG were obtained from
Dianova (Hamburg, Germany). Alexa Fluor-conjugated secondary
antibodies were obtained from Molecular Probes (Eugene,
Oregon, USA). Biotinylated-secondary antibodies were purchased
from Vector Laboratories (Burlingame, CA, USA).
Animals
Cln6-defective nclf mice (B6.Cg-Cln6
nclf) were purchased from
The Jackson Laboratory (Bar Harbor, ME, USA). Animals were
maintained according to the institutional guidelines of the animal
facility of the University Medical Center Hamburg-Eppendorf.
Killing and removal of brains from mice were approved by the
local animal welfare officer, Dr. A. Haemisch (#ORG 532).
Tissues were either immediately frozen and kept at 280uC prior
analysis or used directly for analytical experiments.
Cell cultures and transfections
Baby hamster kidney 21 (BHK) cells were kindly provided by
Dr. K. von Figura (University of Go ¨ttingen; [46]) and grown in
DMEM supplemented with 10% FCS at 37uC, 5% CO2,
transiently transfected with Lipofectamine 2000 according to the
manufacturer’s instructions and further processed 18 h post-
transfection. Hippocampal neurons from C57Bl/6J and nclf mice
were prepared on postnatal day 0 as previously described [47] and
plated at a density of 150 cells/mm
2 on poly-L-lysine coated
vessels.
Metabolic labelling and immunoprecipitation
BHK cells expressing murine wild-type or mutant GFP-Cln6
were starved for 1 h in methionine-free MEM, labelled for 2 h
with [
35S]-methionine (75 mCi/ml) and either harvested or chased
in DMEM supplemented with 10% FCS and methionine (5 mM)
for up to 24 h. Where indicated, proteasome inhibitor epoxomicin
(2 mM) was added during the pulse and chase periods. Cells were
then lysed in PBS containing 1% Triton-X100, 1% bovine serum
albumin and protease inhibitor cocktail followed by immunopre-
cipitation of GFP-Cln6 fusion proteins with anti-GFP antibody
(5 mg/0.8 ml) and protein A agarose (Sigma). After washing,
immunoprecipitates were solubilized and separated by SDS–
PAGE under reducing conditions followed by fluorography. The
radiolabeled polypeptides were quantified by excision of the bands
from the gel, solubilization in Solvable tissue solubilizer (Perkin
Elmer, Rodgau, Germany) and scintillation counting using a liquid
scintillation analyzer Tri-Carb 2900TR (Perkin Elmer).
Histological and microscopical analysis
For electron microscopic analysis, brains were dissected from
C57Bl/6J and nclf mice at different ages, fixed with 4%
paraformaldehyde and 1% glutaraldehyde and embedded in
epoxy resin. Hippocampal neurons at DIV14 were fixed 30 min
with 3% glutaraldehyde on the culture plates, collected by
scraping, further fixed over night as a pellet with 3% glutaralde-
hyde and embedded in epoxy resin. Quantification of autophago-
somes was performed as previously described [48]. Pictures were
taken from randomly selected cells from each sample. For each
picture, the number of autophagosomes and the total cellular area
were determined and the number of autophagic structures per cell
cytoplasmic area was calculated.
For GFAP-histological analysis brains were immersion fixed in
4% paraformaldehyde in 0.1 M phosphate buffer and 40 mm
sections were cut and processed for immunohistochemical staining
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sequential incubation in polyclonal rabbit anti-GFAP (1:5000),
biotinylated goat anti-rabbit (1:1000), Vectastain Elite ABC
reagent (1:1000) and immunohistochemistry revealed by develop-
ment with DAB (see above).
Immunohistochemistry for p62, CD68 and GFAP staining was
performed essentially as described previously [49,50]. Mice were
anaesthetized and perfused with PBS followed by 4% parafor-
maldehyde (PFA) (w/v) in PBS, pH 7.4. Brains were removed,
postfixed in the same fixative over night and subsequently
cryoprotected by incubation in 30% (w/v) sucrose in PBS over
night. Free floating 35 mm thick slices were sagittally sectioned
using a Leica 9000s sliding microtome. Sections for IHC were
washed two times with PBS and subsequently blocked with
blocking solution (1% BSA (w/v), 4% (v/v) normal goat serum,
0.02% (w/v) saponin in PBS). Antibodies were appropriately
diluted in antibody diluent solution (1% BSA (w/v), 1.5% (v/v)
normal goat serum, 0.02% (w/v) saponin in PBS) and sections
incubated over night at 4uC with primary antibodies. After
washing four times with washing solution (0.02% (w/v) saponin in
PBS), sections were incubated with biotinylated secondary
antibodies (diluted in antibody diluent solution) for one hour at
room temperature. After another four washes with washing
solution, the sections were incubated with Vectastain ABC Elite
solution (Vector Laboratories, Burlingame, CA, USA) for
1.5 hours at room temperature. After the last four washes, sections
were developed using DAB substrate solution, mounted and
coverslipped with Mowiol or DPX.
Double-immunofluorescence and autofluorescence were evalu-
ated by confocal laserscan microscopy with a Leica Sp2 confocal
microscope. Tissue sections were processed as described above
except incubation for 1 hour with fluorophore-conjugated sec-
ondary antibodies (rabbit Alexa Fluor 488 and mouse/rat Alexa
Fluor 633) instead of biotin-conjugated secondary antibodies.
Sections were coverslipped subsequently in Mowiol containing
DABCO (1,4-diazabicyclo(2,2,2)octan). For evaluation of auto-
fluorescence, unstained sections were coverslipped as above and
evaluated with the 488 nm laser line and emission at 519 nm 6
20 nm.
Western blot
Tissue homogenates were prepared as follows: tissues (whole
brain or cerebellum) were dissected from mice at each age and
homogenized in either 1 ml (brain) or 0.5 ml (cerebellum) 20 mM
Tris-HCl, pH 7.5, containing 150 mM NaCl, protease inhibitor
cocktail and PhosSTOP phosphatase inhibitor cocktail using a
dounce homogenizer. Proteins were solubilized by the addition of
Triton X-100 to a final concentration of 1%. Extracts were cleared
from insoluble material by ultracentrifugation for 1 h at
100,0006g,4 uC, using a Sorvall Discovery M120 centrifuge and
protein concentration of the supernatant was determined with
Bradford protein assay (Bio-Rad, Munich, Germany). Alterna-
tively, for assessment of LC3 levels and fractionation of proteins,
total brains were homogenized in five volumes of 250 mM sucrose
buffer containing 50 mM Tris-HCl pH 7.4, 1 mM EDTA and
protease inhibitor cocktail. Nuclei were cleared by centrifugation
at 5006g for 10 minutes at 4uC and supernatants were lysed with
an equal volume of sucrose buffer containing 1% Triton X-100 for
one hour at 4uC. Resulting lysates were either used directly or
further separated into Triton X-100 soluble/insoluble fractions by
centrifugation at 13,0006g for 15 minutes at 4uC. Supernatants
(representing the detergent-soluble fractions) were removed and
pellets (representing the detergent-insoluble material) resuspended
in 1% SDS in PBS with inhibitor cocktail.
Samples were separated by SDS-PAGE and blotted onto
nitrocellulose membrane. Incubation of the primary antibody was
followed by incubation with horseradish peroxidase-conjugated
secondary antibody (1:5,000) and visualization of the bands with
enhanced chemiluminescence (ECL) and ChemiDoc XRS (Bio-
Rad). Densitometric quantification was performed using the spot
density function of ChemiDoc XRS.
Supporting Information
Figure S1 Astrocytosis in the cerebellum of nclf mice.
Immunohistochemical staining for GFAP in the cerebellum of
54 weeks old wild-type (wt) and nclf mice. Scale bars: 500 mm. In
the lower panel, higher magnification images of the areas marked
by the white rectangles are shown.
(TIF)
Figure S2 Immunohistochemistry of p62 and LC3. A)
Immunohistochemical analysis of brain sections (35 mm thickness)
of 20 and 54 weeks old mouse brain showed p62-positive
aggregates in nclf brain regions. Scale bar: 20 mm. B) Immuno-
histochemical staining of LC3 in 54 weeks old wt and nclf
hippocampus showed LC3-positive structures (arrows) in the nclf
brain. Scale bar: 20 mm.
(TIF)
Figure S3 No induction of autophagy by Beclin-1. Beclin-
1 expression was examined by western blotting of brain extracts of
wild-type (wt) and nclf mice at different ages. Tubulin was used as
loading control.
(TIF)
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